IMU 9.26% 5.9¢ imugene limited

Ann: Imugene Corporate Presentation, page-60

  1. 3,008 Posts.
    lightbulb Created with Sketch. 1564
    Summary of the afternoon... TLDR read the bold parts.
    Hopper - Share price
    Let's talk about the elephant in the room... the Share price.
    We have opened up a communications via email about a year ago. Without fail we get 10s of hundreds of emails every day about share price. We are as mystified as you as to why it is so low.

    We get people writing conspiracy theories such as BP are smashing it down and acquiring heaps and then will sell us off cheaply. Hopper assurers us, they watch the register all the time, this is not happening. Lastly, all personnel are as deeply invested and in the red, and not happy, but will continue on.

    LC - general talk about the platforms and chemo through to immunotherapy

    Direct Quote "We know for a fact if we can get our product to the Tumour it will kill it" Perhaps commenting on the new delivery system

    YF - talking on how the virus was made

    He went through the way they got to CF33, you can see all about this on the now famous video of him explaining this years ago.Many viruses are chosen to kill a particular cancer. Direct quote... Let me say this again, lets throw this at every cancer type. Then he went to talk about the various viruses and how long it would take to go through the various protocols for viruses. When LC showed him the protocols they had in mind, he said direct quote "No way FDA will approve that"

    Direct quotes...
    We clearly can kill cancer
    We clearly can turn on the microenvironment

    LC - Back to LC for questions...

    Direct question: what's up with B cell, why not in preso (or at end)?
    LC We are focusing on CF33, since we have Yuman here, that's my fault, But B cell is still alive.
    Direct question: so B cell is not dead?
    No, very much alive.
    BP is very selective at the moment, they took on another drug that extended for a few months, (but was still toxic or added toxicity) go figure.
    Monil Shah is in discussions all the time.
    Weitzmann the new CMO, stays at places for a short time, we want him to stay, we will try to get him to stay.
    One slot opens up for a new patient and it gets filled immediately (on the vaccinia trials) there are indeed people lining up for this trial.




 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.